These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1871933)
1. [Use of photodynamic therapy in the treatment of refractory carcinoma in situ]. Benson RC Urologe A; 1991 May; 30(3):158-61; discussion 161-2. PubMed ID: 1871933 [TBL] [Abstract][Full Text] [Related]
2. [Photodynamic procedures in urology]. Jocham D Urologe A; 1994 Nov; 33(6):547-52. PubMed ID: 7817455 [TBL] [Abstract][Full Text] [Related]
3. Integral photodynamic therapy of superficial bladder tumors with special reference to carcinoma in situ. Hisazumi H; Naito K; Uchibayashi T; Hirata A; Komatsu K Scand J Urol Nephrol Suppl; 1991; 138():161-5. PubMed ID: 1785000 [TBL] [Abstract][Full Text] [Related]
4. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?]. Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172 [TBL] [Abstract][Full Text] [Related]
5. [Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder--report of 30 cases]. Tian ME Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):304-6. PubMed ID: 2533889 [TBL] [Abstract][Full Text] [Related]
6. [History of photodynamic therapy--past, present and future]. Kato H Gan To Kagaku Ryoho; 1996 Jan; 23(1):8-15. PubMed ID: 8546474 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. Prout GR; Lin CW; Benson R; Nseyo UO; Daly JJ; Griffin PP; Kinsey J; Tian ME; Lao YH; Mian YZ N Engl J Med; 1987 Nov; 317(20):1251-5. PubMed ID: 2959863 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of bladder cancer by Nd:YAG laser local irradiation and whole-bladder photodynamic therapy with hematoporphyrin derivative]. Li CL; Xu BZ; Shong XY Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):458-60. PubMed ID: 7720506 [TBL] [Abstract][Full Text] [Related]
9. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study]. Jocham D; von Wietersheim J; Pflüger H; Steiner H; Doehn C; Büttner H; Böhle A; Kausch I Aktuelle Urol; 2009 Mar; 40(2):91-9. PubMed ID: 19214951 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of bladder carcinoma. Rosenberg SJ; Williams RD Urol Clin North Am; 1986 Aug; 13(3):435-44. PubMed ID: 2941910 [TBL] [Abstract][Full Text] [Related]
11. [Whole bladder wall laser irradiation to prevent bladder cancer recurrence with intravesical HpD and ascorbic acid]. Li C; Chen Y; Wang Q Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):463-5. PubMed ID: 10920885 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivative. Lin CW; Amano T; Rutledge AR; Shulok JR; Prout GR Cancer Res; 1988 Nov; 48(21):6115-20. PubMed ID: 2971434 [TBL] [Abstract][Full Text] [Related]
13. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. D'Hallewin MA; Baert L Urology; 1995 May; 45(5):763-7. PubMed ID: 7747371 [TBL] [Abstract][Full Text] [Related]
14. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors. Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062 [TBL] [Abstract][Full Text] [Related]
15. The use of hematoporphyrin derivative (HpD) in the localization and treatment of transitional cell carcinoma (TCC) of the bladder. Benson RC Prog Clin Biol Res; 1984; 170():795-804. PubMed ID: 6241716 [No Abstract] [Full Text] [Related]
16. [Photodynamic therapy for genitourinary carcinomas--report of 26 tumors in 17 patients]. Huang JG Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):55-7. PubMed ID: 1832375 [TBL] [Abstract][Full Text] [Related]
17. [Electron microscopic observation on human bladder cancer tissue after photodynamic therapy]. Zhou CN Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Jun; 10(3):176-8. PubMed ID: 2972405 [No Abstract] [Full Text] [Related]
18. [Quantitative immunocytology as a marker for indications and follow-up of recurrence prevention of superficial urinary bladder cancers]. Schneider AW; Huland E; Huland H Urologe A; 1989 Sep; 28(5):289-91. PubMed ID: 2815438 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract. Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955 [TBL] [Abstract][Full Text] [Related]
20. A trial manufacture of a motor-driven laser light scattering optic for whole bladder wall irradiation. Hisazumi H; Miyoshi N; Misaki T Prog Clin Biol Res; 1984; 170():239-47. PubMed ID: 6241679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]